Bellevue Global Life Science Investors LLC - 21 Feb 2023 Form 4 Insider Report for Bellevue Life Sciences Acquisition Corp. (OSRH)

Role
10%+ Owner
Signature
By: Bellevue Capital Management LLC, Its Manager /s/ Kuk Hyoun Hwang, Managing Member
Issuer symbol
OSRH
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 15:30:35 UTC
Previous filing
16 Feb 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLAC Common Stock Other $0 +225,000 +12% $0.000000 2,025,000 21 Feb 2023 Direct F1, F2
transaction BLAC Common Stock Other $0 -4,500 -0.22% $0.000000 2,020,500 21 Feb 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor") whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
F2 Represents the shares that will no longer be forfeited by the Sponsor as a result of the underwriters exercising the over-allotment option in full.
F3 Represents an additional 4,500 shares that were transferred from the Sponsor to the underwriters as a result of the underwriters exercising the over-allotment option in full.